Rep. Matt Gaetz (R-Fla) recently filed an amendment to explore the therapeutic potential of magic mushrooms and MDMA for military service members through research that would be included in the annual defense bill as an attachment to the National Defense Authorization Act (NDAA).
Gaetz has a background in supporting projects concerning marijuana legalization as well as a keen interest in psychedelics reform. According to Marijuana Moment, in 2019 Gaetz cosponsored an appropriations amendment led by Rep. Alexandria Ocasio-Cortez for the removal of an existing stipulation that would inhibit researching the therapeutic potential of Schedule I drugs.
In the latest proposal, a provision by Rep. Seth Moulton requests that the Department of Defense (DOD) undertake a study on the efficacy of cannabis as an opioid alternative. This amendment is already attached to NDAA for Fiscal Year 2023.
Now, Gaetz is requesting that it also covers psilocybin mushrooms and MDMA, therefore taking the three substances as alternatives to prescription opioids for members of the Armed Forces on terminal leave preceding separation, retirement or release from active duty.
Eligibility would be limited to service members with post-traumatic stress disorder, a traumatic brain injury or “any other condition involving severe pain.”
Prior to House floor consideration, the proposal must be presented to a panel in the House Rules Committee.
The House Appropriations Committee’s new plan regarding the 2023 Fiscal Year expenses bill for Commerce, Justice, Science and Related Agencies (CSJ) also requests a federal review of psilocybin policy, with special consideration of limitations to state, local and tribal psychedelic programs.
Recently two federal health principals at the National Institutes of Health have admitted in a letter to U.S. senators that federal prohibition constitutes barriers to the study of psychedelics’ benefits.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.